CompoAtlas

Sonova TM 400

Natural health product licensed in Canada

Licence holder
Arcadia Biosciences, Inc.
NPN or DIN-HM
80035974
Status
Active licence
Licence date
28 September 2012
Revision date
Not provided
Form
Liquide
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Carthamus tinctorius

Source : Graine(s)

Potency : 44 % GLA

1.1 gNot calculated
Carthamus tinctorius

Source : Carthame

Potency : 44 % GLA

1.1 gNot calculated
Carthamus tinctorius

Source : Gamma-Linolenic acid

Potency : 44 % GLA

1.1 gNot calculated

Non-medicinal ingredients

Extrait de romarin, Palmitate d'ascorbyle, mélange de tocophérols, Huile végétale, Acide citrique, Acide oléique, Mono and diglycerides

PopulationAgeQuantity per servingFrequency
AdultesNot specified0.25 Cuillère à thé1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Omega-6 fatty acids supplement for the maintenance of good health.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80035974

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line